心血管康复医学杂志2024,Vol.33Issue(3) :368-372.DOI:10.3969/j.issn.1008-0074.2024.03.27

肥厚性梗阻型心肌病治疗的研究进展

Research progress in the treatment of hypertrophic obstructive cardiomyopathy

梁雅婷 张瑶
心血管康复医学杂志2024,Vol.33Issue(3) :368-372.DOI:10.3969/j.issn.1008-0074.2024.03.27

肥厚性梗阻型心肌病治疗的研究进展

Research progress in the treatment of hypertrophic obstructive cardiomyopathy

梁雅婷 1张瑶1
扫码查看

作者信息

  • 1. 哈尔滨医科大学附属第二医院心血管内科,黑龙江哈尔滨 150081
  • 折叠

摘要

肥厚性心肌病是一种常染色体显性遗传病,分为梗阻型和非梗阻型两类.其中肥厚性梗阻型心肌病是导致青年人和运动员猝死的常见原因,也是心脏猝死的重要原因.目前肥厚性梗阻型心肌病的治疗主要包括药物治疗、外科室间隔切除术、介入治疗和心脏再同步治疗.本文对肥厚性梗阻型心肌病综合治疗的研究进展进行了综述,以期为肥厚性梗阻型心肌病治疗方案的选择提供理论依据和参考.

Abstract

Hypertrophic cardiomyopathy is an autosomal dominant disease,which can be divided into obstructive type and non-obstructive type.Hypertrophic obstructive cardiomyopathy is a common cause of sudden death in young people and athletes,and is also an important cause of sudden cardiac death.Currently,the treatment of hyper-trophic obstructive cardiomyopathy mainly includes drug therapy,surgical septal myectomy,interventional therapy and cardiac resynchronization therapy.This paper is the review of research progress of the comprehensive treatment of hypertrophic obstructive cardiomyopathy,in order to provide theoretical basis and reference for the selection of the treatment scheme of hypertrophic obstructive cardiomyopathy.

关键词

心肌病,肥厚性/药物疗法/治疗

Key words

Cardiomyopathy,hypertrophic/Drug therapy/Therapy

引用本文复制引用

出版年

2024
心血管康复医学杂志
福建省康复医学会 中国康复医学会

心血管康复医学杂志

CSTPCD
影响因子:1.157
ISSN:1008-0074
段落导航相关论文